Abstract
Purpose
Sleeve gastrectomy (SG) is a widely used surgical method in the treatment of obesity. This study aimed to reveal the histopathological changes in SG materials and to investigate the prevalence of clinically important lesions requiring follow-up.
Materials and Methods
Three hundred five patients’ data who underwent SG were analyzed. Cases were divided into three groups as normal, chronic inactive gastritis (CIG), and chronic active gastritis (CAG). Age, gender, and body mass index (BMI) of the three groups and the differences in the gastritis parameters of CIG and CAG groups were compared.
Results
Thirty-three patients (10.8%) were in the normal group, 145 (47.5%) were in the CIG group, and 127 (41.6%) were in the CAG group. Preoperative endoscopic examination was performed in all cases, but Helicobacter pylori (HP) treatment was not applied. HP were detected in 39.3%, atrophy in 3.9%, intestinal metaplasia (IM) in 4.9%, and lymphoid follicle (LF) in 30% of the cases. Inflammation, atrophy, IM, LF, and HP were significantly higher in the CAG group. The proton pump inhibitor (PPI)–related changes were seen in 20 cases and it was more frequent in the CIG group. Intramucosal signet ring cell carcinoma was detected in 1 case. Endocrine cell hyperplasia and dysplasia were present in 7 cases with CAG. Multiple grade 1 neuroendocrine tumors were detected in just 1 case.
Conclusion
In our SG specimens, HP and clinically important lesions were significantly higher in the CAG group. Pathological examination should be carefully done as the lesions detected in SG specimens can change patient management.
Graphical Abstract
Similar content being viewed by others
References
Schauer PR, Schirmer BD. The surgical management of obesity. In: Schwartz SI, editor. Principles of surgery. 10th ed: New York: McGraw-Hill; 2015. p. 1099.
Boutari C, Mantzoros CSA. update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;2022(133):155217. https://doi.org/10.1016/j.metabol.2022.155217.
WHO. Obesity and overweight: The World Health Organisation (WHO) Reports; 2016.
Kluge HHP. Weltgesundheitsorganisation Regionalbüro für Europa. WHO European regional obesity report. 2022;n.d. https://apps.who.int/iris/bitstream/handle/10665/353747/9789289057738-eng.pdf
TUİK, (2020, 04 June) Türkiye Sağlık Araştırması Ankara: Türkiye İstatistik Kurumu Sayı: 2019;33661. https://data.tuik.gov.tr/Bulten/Index?p=Turkey-Health-Survey-2019-33661
Barak N, Ehrenpreis ED, Harrison JR, et al. Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations. Obes Rev. 2002;3:9–15.
Fujimoto A, Hoteya S, Iizuka T, et al. Obesity and gastrointestinal diseases. Gastroenterol Res Pract. 2013;2013:760574.
Wu JC, Mui IM, Cheung CM, et al. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007;132:883–9.
Ogorek CP, Cohen S. Gastroesophageal reflux disease: new concepts in pathophysiology. Gastroenterol Clin North Am. 1989;18:275–92.
NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115:956–96.
Gagner M, Deitel M, Erickson AL, et al. Survey on laparoscopic sleeve gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg. 2013;23(12):2013–7.
Komaei I, Currò G, Mento F, et al. Gastric histopathologic findings in South Italian morbidly obese patients undergoing laparoscopic sleeve gastrectomy: is histopathologic examination of all resected gastric specimens necessary? Obes Surg. 2020;30(4):1339–46.
Almazeedi AS, Al-Sabah S, Al-Mulla A, Al-Murad A, Al-Mossawi A, Al-Enezi K, Jumaa T, Bastaki W. Gastric histopathologies in patients undergoing laparoscopic sleeve gastrectomies. Obes Surg. 2013;23(3):314–9. https://doi.org/10.1007/s11695-012-0821-y.
Turan G, Kocaöz S. Helicobacter pylori infection prevalence and histopathologic findings in laparoscopic sleeve gastrectomy. Obes Surg. 2019;29(11):3674–9. https://doi.org/10.1007/s11695-019-04052-7.
Safaan T, Bashah M, El Ansari W, et al. Histopathological changes in laparoscopic sleeve gastrectomy specimens: prevalence, risk factors, and value of routine histopathologic examination. Obes Surg. 2017;27:1741–9.
Canil AM, Lossa A, Termine P, et al. Histopathology findings in patients undergoing laparoscopic sleeve gastrectomy. Obes Surg. 2018;28(6):1760–5.
Erkinuresin T, Demirci H, Cayci HM, et al. The relationship between histopathologic findings and weight loss in laparoscopic sleeve gastrectomy. Obes Surg. 2020;30(2):478–82. https://doi.org/10.1007/s11695-019-04185-9.
Ohanessian SE, Rogers AM, Karamchandani DM. Spectrum of gastric histopathologies in severely obese American patients undergoing sleeve gastrectomy. Obes Surg. 2016;26(3):595–602.
Raess PW, Baird-Howell M, Aggarwal R, et al. Vertical sleeve gastrectomy specimens have a high prevalence of unexpected histopathologic findings requiring additional clinical management. Surg Obes Rel Dis. 2015;11(7):1020–4.
Taha-Mehlitz S, Mongelli F, Sykora M, et al. Routine histopathologic examination of the resected specimen after laparoscopic sleeve gastrectomy – what can be expected? Acta Chir Belg. 2021;121(6):380–5. https://doi.org/10.1080/00015458.2020.1794335.
Demirbaş BT, Erdim A, Celikel C, et al. Is it necessary to send the sleeve gastrectomy specimens to pathology? Surg Laparosc Endosc Percutan Tech. 2019;29:117–9.
Al Saady R, Ejeckam G. Histopathological findings in laparoscopic sleeve gastrectomy specimens. Qatar Med J. 2019;2019(1):5. https://doi.org/10.5339/qmj.2019.5.19.
Kopach P, Genega EM, Shah SN, et al. The significance of histologic examination of gastrectomy specimens: a clinicopathologic study of 511 cases. Surg Obes Relat Dis. 2017;13:463–7.
Doğan U, Süren D, Oruç MT, et al. Spectrum of gastric histopathologies in morbidly obese Turkish patients undergoing laparoscopic sleeve gastrectomy. Eur Rev Med Pharmacol Sci. 2017;21(23):5430–6.
Sabbah NA, Saoud CZ, Deeb M, et al. Helicobacter pylori prevalence in laparoscopic sleeve gastrectomy specimen. Gastroenterol Res Pract. 2020;10(2020):8843696. https://doi.org/10.1155/2020/8843696.
Di Palma A, Alhabdan S, Maeda A, et al. Unexpected histopathological findings after sleeve gastrectomy [published online September 11, 2019]. Surg Endosc. 2020;34(5):2158–63. https://doi.org/10.1007/s00464-019-07002-7.
Aljerian K. Histopathological findings in laparoscopic sleeve gastrectomy specimens from patients with obesity in Saudi Arabia. Gastroenterol Res Pract. 2018;2018:1–4. https://doi.org/10.1155/2018/1702705.
Hansen SK, Pottorf BJ, Hollis Jr H, et al. Is it necessary to perform full pathologic review of all gastric remnants following sleeve gastrectomy? Am J Surg. 2017;214(6):1151–5.
Nowak K, Di Palma A, Chieu K, et al. Histologic and cost-benefit analysis of laparoscopic sleeve gastrectomy specimens performed for morbid obesity. Arch Pathol Lab Med. 2021;145(3):365–70. https://doi.org/10.5858/arpa.2020-0084-OA.
Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter. 2014;1:1–5.
Mentis A, Lehours P, Mégraud F. Epidemiology and diagnosis of helicobacter pylori infection. Helicobacter. 2015;20:1–7.
Shanti H, Almajali N, Al-Shamaileh T, et al. Helicobacter pylori does not affect postoperative outcomes after sleeve gastrectomy. Obes Surg. 2017;27(5):1298–301.
Gonzalez-Heredia R, Tirado V, Patel N, et al. Is Helicobacter pylori associated with an increased complication rate after sleeve gastrectomy? Bariatr Surg Pract Patient Care. 2015;10(1):15–8.
Khatoon J, Rai RP, Prasad KN. Role of Helicobacter pylori in gastric cancer: updates. World J Gastrointest Oncol. 2016;8(2):147–58.
Huang TC, Lee CL. Diagnosis, treatment, and outcome in patients with bleeding peptic ulcers and Helicobacter pylori infections. Biomed Res Int. 2014;2014:658108.
Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554–60.
Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol. 2010;105:493–8.
Leung W, Sung J. Intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther. 2002;16(7):1209–16.
Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353–67.
Vrabie CD, Cojocaru M, Waller M, et al. The main histopathological gastric lesions in obese patients who underwent sleeve gastrectomy. Dicle Med J. 2010;37:97–103.
Odze RD, Goldblum JR. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. Philadelphia (PA): Saunders-Elsevier; 2014. p. 361.
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934–59.
Mottin CC, Cruz RP, Gomes Thomé G, et al. Carcinoid tumors and morbid obesity. Obes Surg. 2009;19(2):247–9.
Al-Harbi O, Shakir M, Al-Brahim N. Gastric carcinoid and obesity: association or coincidence? Report of two cases and literature review. Case Rep Gastrointest Med. 2013;2013:848075.
Sauerland S, Angrisani L, Belachew M, et al. European Association for Endoscopic Surgery. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc. 2005;19(2):200–21. https://doi.org/10.1007/s00464-004-9194-1.
SAGES Guidelines Committee. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Obes Relat Dis. 2009;5(3):387–405. https://doi.org/10.1016/j.soard.2009.01.010.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
Approval was obtained from the institutional ethics committee (ethic approval number is 316). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Consent to Participate
Informed consent was obtained from all individual participants included in the study.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key points
• There is no accepted standard protocol for histopathologic examination of sleeve gastrectomy specimens and studies have reported a wide range of findings.
• Inflammation, atrophy, intestinal metaplasia, lymphoid follicle, and HP were significantly higher in the chronic active gastritis group than in the chronic inactive gastritis group.
• Unexpected but clinically important lesions such as neuroendocrine tumor and signet ring cell carcinoma can be detected.
• Pathological examination should be carefully done in sleeve gastrectomy specimens. Application of standard procedures in the pathological examination can contribute to learning the lesions associated with obesity.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Paşaoğlu, H.E., Özcan, T.B., Öztürk, Ç. et al. Histopathological Findings in Turkish Patients Undergoing Sleeve Gastrectomy: Is Histopathologic Examination of Sleeve Gastrectomy Specimens Clinically Important?. OBES SURG 33, 2808–2815 (2023). https://doi.org/10.1007/s11695-023-06728-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-06728-7